• Bacterial
  • Vaxsafe^® MG Vaccine (living)
  • Vaxsafe^® MS Vaccine (living)
  • Vaxsafe^® PM Vaccine (living)
  • Vaxsafe^® ST Vaccine (living)
• Viral
• Vaxsafe^® HVT Vaccine (living)
• Vaxsafe^® IB Vaccine (living)
• Vaxsafe^® IBD Vaccine (living)
• Vaxsafe^® ND Vaccine (living)
• Vaxsafe^® RIS Vaccine (living)
• Vaxsafe^® SBH Vaccine (living)
• Protozoal
  • Eimeriavax 4m
  • Eimeriavax 3m

Vaxsafe^® HVT

Vaxsafe^® HVT is a high titred Marek's Type 3 live cell associated vaccine being produced by Bioproperties in Australia to control Marek's disease in broilers.

Vaxsafe^® HVT induces immunity to Marek's disease and reduces the incidence of T-cell transformation.

Primarily mass applied via sub-cutaneous or in ovo injection, Vaxsafe^® HVT was first registered in 1998.

Registration # 50538.